Senseonics Holdings, Inc. Schedules First Quarter 2019 Earnings Release & Conference Call for May 9, 2019 at 4:30 p.m. Easter...
April 25 2019 - 04:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and commercialization
of a long-term, implantable continuous glucose monitoring (CGM)
system for people with diabetes, today announced that it plans to
release its first quarter 2019 financial results after market close
on Thursday, May 9, 2019.
Management will hold a conference call to review the company’s
first quarter 2019 performance starting at 4:30 p.m. (Eastern Time)
on the same day. The conference call will be concurrently webcast.
The link to the webcast will be available on Senseonics Holdings,
Inc. website at www.senseonics.com by navigating to “Investor
Relations,” and then “Events & Publications,” and will be
archived there for future reference. To listen to the conference
call, please dial 888-378-4398 (US/Canada) or 786-789-4775
(International), passcode 756769, approximately ten to five minutes
prior to start time.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190425005889/en/
INVESTOR CONTACTLynn Lewis or Philip TaylorInvestor
Relations415-937-5406investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From Feb 2024 to Mar 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Mar 2023 to Mar 2024